Coronavirus testing for US workplaces offered by Konica Minolta

Biotech unit to field clients directly as safety concerns mount

20200416N Ambry Genetics

Ambry Genetics has the capacity to conduct 2,000 polymerase chain reaction tests daily. (Photo courtesy of the company)

TAKESHI HASHIMOTO, Nikkei staff writer

TOKYO -- Konica Minolta plans to offer a coronavirus testing service for U.S. businesses in fields such as logistics and infrastructure that look to prevent outbreaks at warehouses and other sites where staff continue to work despite lockdowns.

California-based subsidiary Ambry Genetics will perform the service, becoming one of the first testing providers in the U.S. to field requests from commercial customers.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.